PolyNovo Limited (ASX:PNV)

Market Cap	808.29M
Revenue (ttm)	115.58M
Net Income (ttm)	5.91M
Shares Out	690.84M
EPS (ttm)	0.01
PE Ratio	139.32
Forward PE	78.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600,348
Average Volume	3,267,469
Open	1.140
Previous Close	1.130
Day's Range	1.140 - 1.180
52-Week Range	0.930 - 2.780
Beta	1.69
RSI	49.95
Earnings Date	May 23, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 254
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PNV